Supplementary Figure S1 from Early Detection of Molecular Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA

Figure S1. Flowchart of patient selection and enrollment. In total, 50 patients and 195 paired samples (ctDNA and BM DNA) from this population can be analyzed. In the last row, plasma samples from included patients at separate timepoint were depicted. BM, bone marrow; C2D1, Cycle 2 day 1; C3D1, Cycle 3 day 1; C4D1, Cycle 4 day 1